James Cassella
Förmögenhet: - $ per 2026-05-31
Förmögenhet: - $ per 2026-05-31
James V.
Cassella is currently Chief Development Officer at Trevi Therapeutics, Inc. since 2024.
Formerly, Chief Development Officer at Sun Pharmaceutical Industries, Inc. from 2023 to 2024.
Chief Development Officer & Senior Vice President at Concert Pharmaceuticals, Inc. from 2015 to 2023.
CSO, Executive VP-Research & Development at Alexza Pharmaceuticals, Inc. from 2013 to 2015.
Senior VP-Clinical Research & Development at Neurogen Corp.
from 1989 to 2004.
Assistant Professor at Oberlin College.
Education includes a doctorate from Dartmouth College and an undergraduate degree from the University of New Haven.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-04-06 | 0 ( -.--% ) | - $ | 2026-05-31 |
| Företag | Position | Start |
|---|---|---|
| TREVI THERAPEUTICS, INC. | Företagsledare/Principal | 2024-09-30 |
| Företag | Position | Slut |
|---|---|---|
Sun Pharmaceutical Industries, Inc.
Sun Pharmaceutical Industries, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Företagsledare/Principal | 2024-09-01 |
| CONCERT PHARMACEUTICALS, INC. | Företagsledare/Principal | 2023-03-01 |
| ALEXZA PHARMACEUTICALS, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2015-01-29 |
Neurogen Corp.
Neurogen Corp. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Teknisk/Vetenskaplig/F&U Direktör | 2004-06-01 |
Oberlin College
Oberlin College Other Consumer ServicesConsumer Services Functions as a College/University | Företagsledare/Principal | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 8 |
|---|---|
Neurogen Corp.
Neurogen Corp. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Health Technology |
Alexza Pharmaceuticals, Inc.
Alexza Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for the acute treatment of central nervous system conditions | Health Technology |
Concert Pharmaceuticals, Inc.
Concert Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel medicines | Health Technology |
Oberlin College
Oberlin College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dartmouth College
Dartmouth College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of New Haven
University of New Haven Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sun Pharmaceutical Industries, Inc.
Sun Pharmaceutical Industries, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Trevi Therapeutics, Inc.
Trevi Therapeutics, Inc. BiotechnologyHealth Technology Engages in development of treatment for cough conditions | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån